Inspired by Cannabis’s spiritual history, Namaste will be present on store shelves beginning October 17th
Vancouver, British Columbia – October 15, 2018 – On October 4, 2018, Bevo Agro Inc. (TSXV: BVO) announced that it has signed an Arrangement Agreement dated October 4, 2018 with Sun Pharm Investments Ltd. (“Sun Pharm”) for a reverse take-over of Bevo, and announced its intent to change its name to Zenabis Global Inc (Zenabis). This combined entity will have almost 3.5 million square feet in available production space.1.
Zenabis is excited to announce the launch of “Namaste” – a comprehensive suite of adult-use recreational cannabis products. Crafted with the same exceptional quality found in Zenabis medical offerings, the Namaste brand will deliver a premium experience for consumers.
“When we developed Namaste, we wanted a name that not only reflected our personal values, but one that also showed respect for the people and the world around us,” said Dr. Natasha Ryz, Chief Science Officer, Zenabis. “The name ‘Namaste’ embodies all this and more. It not only plays homage to the historical role cannabis has played in spirituality, but it also serves as a positive reminder to always be mindful and to stay present.”
Namaste will make its debut on Canada’s first day of legalization – October 17, 2018. Namaste adult-use recreational cannabis products will be available in licensed retail stores throughout New Brunswick, Nova Scotia and British Columbia. The company also has purchase orders from the Yukon Territory and there are plans for additional markets to follow.
“At Zenabis, we believe in being a good neighbor in the communities where we live and work,” said Rick Brar, CEO of Zenabis. “We know consumers want to enjoy new experiences with the confidence that their purchases meet the highest levels of safety and quality. We look forward to bringing this unique offering to our customers to enjoy responsibly across the country.”
Zenabis Key Milestones
About Bevo Agro
Bevo Agro is North America’s leading supplier of propagated agricultural plants, operating approximately 53 acres of state-of-the-art greenhouse facilities on 98 acres of land in Langley, BC and 20 acres of land in Pitt Meadows, BC. The company has entered into a binding agreement to acquire 10.4 acres of greenhouse space on 50 acres of land in Aldergrove, British Columbia (the “Greenhouse Acquisition”). The Company’s main products have been the propagation of vegetable plants such as tomatoes, peppers, cucumbers, and other plants such as bedding plants, flowers and grasses. The Company markets its products to established greenhouse growers, nurseries and retail outlets throughout North America.
About Sun Pharm
Sun Pharm has significant experience in agriculture, technology, pharmaceutical sales, consumer packaged goods, international distribution and brand marketing, with cannabis and cannabis-related purchase orders from the provinces of New Brunswick, British Columbia, Nova Scotia, and Yukon Territory. Sun Pharm is currently a privately-held cannabis company which has one of the largest, federally licensed indoor medical cultivation footprints in Canada, operating two licensed production facilities in British Columbia and New Brunswick, with a third expected to be coming online shortly in Nova Scotia. These facilities encompass 660,000 square feet of indoor pharmaceutical grade cannabis production space, strategically positioned on Canada’s coasts, facilitating national distribution and access to international markets. Sun Pharm is currently working towards globally recognized EU GMP certifications. Sun Pharm has a management team with decades of experience in the industry, with expertise in retail consumer packaged goods, global pharmaceutical sales and manufacturing, quality assurance, and commercialized cultivation. The growing team has more than two decades of experience in organic cultivation and distribution of herbs and nutraceutical products throughout the Americas, North Africa, and the Middle East. Sun Pharm’s sales team has more than two decades in product development, commercialization, and retail and pharmaceutical sales including international distribution.
1 After completion of planned expansions
For more information, visit: https://www.zenabis.com.